Arsenal Medical Inc (Arsenal) is a platform technology company that develops novel therapeutic polymer-based foams. The company’s products include in-situ forming materials, in-situ forming polymeric foam and in-situ curing elastomeric polymer material. It offers in-situ forming materials for local therapy for acute hemorrhage and other critical clinical conditions such as vascular injury and repair. Arsenal’s in-situ forming polymeric foam is designed to control severe, intra-cavity hemorrhage by creating conformal contact and applying pressure to an actively bleeding site. The company offers in-situ curing elastomeric polymer material, which fills and seals the aneurysm sac around a stent graft. It offers services in the areas of advanced materials science to medicine. Arsenal is headquartered in Waltham, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Arsenal Medical Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Arsenal Medical Inc Company Overview
- Arsenal Medical Inc Company Snapshot
- Arsenal Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Arsenal Medical Inc - Pipeline Analysis Overview
- Arsenal Medical Inc - Key Facts
- Arsenal Medical Inc - Major Products and Services
- Arsenal Medical Inc Pipeline Products by Development Stage
- Arsenal Medical Inc Ongoing Clinical Trials by Trial Status
- Arsenal Medical Inc Pipeline Products Overview
- AMI-004
- AMI-004 Product Overview
- Arsenal Foam System - Abdominal Aortic Aneurysm
- Arsenal Foam System - Abdominal Aortic Aneurysm Product Overview
- NeoCast
- NeoCast Product Overview
- NeoCast Clinical Trial
- ResQFoam
- ResQFoam Product Overview
- ResQFoam Clinical Trial
- Arsenal Medical Inc - Key Competitors
- Arsenal Medical Inc - Key Employees
- Arsenal Medical Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Arsenal Medical Inc, Recent Developments
- Jul 11, 2018: FDA approves clinical trial for potentially life-saving trauma foam
- Jun 05, 2017: U.S. Food and Drug Administration Grants Arsenal Medical Investigational Device Exemption Approval to Conduct Clinical Study on ResQFoam Safety and Effectiveness
- Dec 09, 2015: Arsenal Medical Secures Funding from U.S. Army to Advance ResQFoam Trauma Product through Regulatory Approval
- Jan 15, 2015: Arsenal Medical Announces Results of Novel Translational Research Study Determining Human Dose for its Trauma Foam Technology
- Dec 10, 2012: Arsenal Medical’s Foam Technology for Battlefield Injuries Receives $15.5 Million Phase II DARPA Contract
- Dec 10, 2012: Arsenal Medical’s Foam Technology For Battlefield Injuries Receives $15.5m Phase II DARPA Contract
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Arsenal Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Arsenal Medical Inc Pipeline Products by Equipment Type
- Arsenal Medical Inc Pipeline Products by Indication
- Arsenal Medical Inc Ongoing Clinical Trials by Trial Status
- Arsenal Medical Inc, Key Facts
- Arsenal Medical Inc, Major Products and Services
- Arsenal Medical Inc Number of Pipeline Products by Development Stage
- Arsenal Medical Inc Pipeline Products Summary by Development Stage
- Arsenal Medical Inc Ongoing Clinical Trials by Trial Status
- Arsenal Medical Inc Ongoing Clinical Trials Summary
- AMI-004 - Product Status
- AMI-004 - Product Description
- Arsenal Foam System - Abdominal Aortic Aneurysm - Product Status
- Arsenal Foam System - Abdominal Aortic Aneurysm - Product Description
- NeoCast - Product Status
- NeoCast - Product Description
- NeoCast - First in Human Feasibility Study of Pre-Surgical Embolisation of Hypervascular Extra-axial Brain Tumours with the Arsenal Medical Distal Penetrating Embolic System (DPE) to evaluate initial Safety and Performance
- ResQFoam - Product Status
- ResQFoam - Product Description
- ResQFoam - Reducing Exsanguination via In-vivo Expandable Foam
- Arsenal Medical Inc, Key Employees
- Glossary
- Arsenal Medical Inc Pipeline Products by Equipment Type
- Arsenal Medical Inc Pipeline Products by Development Stage
- Arsenal Medical Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ARMUS Corp
- Halt Medical Inc
- ARS Enterprises Inc
